Cancer immunotherapy-induced endocrinopathies: Clinical behavior and therapeutic approach

被引：42

作者：

Iglesias, Pedro ^{[1
]}

机构：

[1] Hosp Ramon & Cajal, Dept Endocrinol, Ctra Colmenar,Km 9-100, E-28034 Madrid, Spain

来源：

EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2018年 / 47卷

关键词：

Cancer; Immunotherapy; Endocrinopathies; Hypophysitis; Thyroiditis; Adrenalitis; Type; 1; diabetes; IPILIMUMAB; MELANOMA; BLOCKADE; ANTIBODIES; NIVOLUMAB; CTLA-4;

D O I：

10.1016/j.ejim.2017.08.019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cancer immunotherapy has proven to be effective in a wide variety of tumors. The use of immune checkpoint blocking monoclonal antibodies has become a standard treatment regimen in some of them as advanced melanoma. However, given the mechanism of action, its use may be associated with immune-related adverse events that may complicate the clinical course and prognosis of patients. Among these are autoimmune endocrine adverse effects, such as hypophysitis, hypo and hyperthyroidism, and adrenal insufficiency. This review focuses on the most relevant and new aspects related to the incidence, clinical presentation, diagnosis and treatment of these adverse effects associated with different types of immune checkpoint inhibitors in cancer immunotherapy. (c) 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

引用

页码：6 / 13

页数：8

共 93 条

[71] Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma [J].

Phan, GQ ;

Yang, JC ;

Sherry, RM ;

Hwu, P ;

Topalian, SL ;

Schwartzentruber, DJ ;

Restifo, NP ;

Haworth, LR ;

Seipp, CA ;

Freezer, LJ ;

Morton, KE ;

Mavroukakis, SA ;

Duray, PH ;

Steinberg, SM ;

Allison, JP ;

Davis, TA ;

Rosenberg, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8372-8377

[72] Ipilimumab for Patients With Advanced Mucosal Melanoma [J].

Postow, Michael A. ;

Luke, Jason J. ;

Bluth, Mark J. ;

Ramaiya, Nikhil ;

Panageas, Katherine S. ;

Lawrence, Donald P. ;

Ibrahim, Nageatte ;

Flaherty, Keith T. ;

Sullivan, Ryan J. ;

Ott, Patrick A. ;

Callahan, Margaret K. ;

Harding, James J. ;

D'Angelo, Sandra P. ;

Dickson, Mark A. ;

Schwartz, Gary K. ;

Chapman, Paul B. ;

Gnjatic, Sacha ;

Wolchok, Jedd D. ;

Hodi, F. Stephen ;

Carvajal, Richard D. .

ONCOLOGIST, 2013, 18 (06) :726-732

[73] Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial [J].

Reck, M. ;

Bondarenko, I. ;

Luft, A. ;

Serwatowski, P. ;

Barlesi, F. ;

Chacko, R. ;

Sebastian, M. ;

Lu, H. ;

Cuillerot, J. -M. ;

Lynch, T. J. .

ANNALS OF ONCOLOGY, 2013, 24 (01) :75-83

[74] Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206 [J].

Ribas, A ;

Camacho, LH ;

Lopez-Berestein, G ;

Pavlov, D ;

Bulanhagui, CA ;

Millham, R ;

Comin-Anduix, B ;

Reuben, JM ;

Seja, E ;

Parker, CA ;

Sharma, A ;

Glaspy, JA ;

Gomez-Navarro, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :8968-8977

[75] Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial [J].

Ribas, Antoni ;

Puzanov, Igor ;

Dummer, Reinhard ;

Schadendorf, Dirk ;

Hamid, Omid ;

Robert, Caroline ;

Hodi, F. Stephen ;

Schachter, Jacob ;

Pavlick, Anna C. ;

Lewis, Karl D. ;

Cranmer, Lee D. ;

Blank, Christian U. ;

O'Day, Steven J. ;

Ascierto, Paolo A. ;

Salama, April K. S. ;

Margolin, Kim A. ;

Loquai, Carmen ;

Eigentler, Thomas K. ;

Gangadhar, Tara C. ;

Carlino, Matteo S. ;

Agarwala, Sanjiv S. ;

Moschos, Stergios J. ;

Sosman, Jeffrey A. ;

Goldinger, Simone M. ;

Shapira-Frommer, Ronnie ;

Gonzalez, Rene ;

Kirkwood, John M. ;

Wolchok, Jedd D. ;

Eggermont, Alexander ;

Li, Xiaoyun Nicole ;

Zhou, Wei ;

Zernhelt, Adriane M. ;

Lis, Joy ;

Ebbinghaus, Scot ;

Kang, S. Peter ;

Daud, Adil .

LANCET ONCOLOGY, 2015, 16 (08) :908-918

[76] Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma [J].

Ribas, Antoni ;

Kefford, Richard ;

Marshall, Margaret A. ;

Punt, Cornelis J. A. ;

Haanen, John B. ;

Marmol, Maribel ;

Garbe, Claus ;

Gogas, Helen ;

Schachter, Jacob ;

Linette, Gerald ;

Lorigan, Paul ;

Kendra, Kari L. ;

Maio, Michele ;

Trefzer, Uwe ;

Smylie, Michael ;

McArthur, Grant A. ;

Dreno, Brigitte ;

Nathan, Paul D. ;

Mackiewicz, Jacek ;

Kirkwood, John M. ;

Gomez-Navarro, Jesus ;

Huang, Bo ;

Pavlov, Dmitri ;

Hauschild, Axel .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) :616-622

[77] Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma [J].

Ribas, Antoni ;

Comin-Anduix, Begona ;

Chmielowski, Bartosz ;

Jalil, Jason ;

de la Rocha, Pilar ;

McCannel, Tara A. ;

Ochoa, Maria Teresa ;

Seja, Elizabeth ;

Villanueva, Arturo ;

Oseguera, Denise K. ;

Straatsma, Bradley R. ;

Cochran, Alistair J. ;

Glaspy, John A. ;

Hui, Liu ;

Marincola, Francesco M. ;

Wang, Ena ;

Economou, James S. ;

Gomez-Navarro, Jesus .

CLINICAL CANCER RESEARCH, 2009, 15 (19) :6267-6276

[78] Pembrolizumab versus Ipilimumab in Advanced Melanoma [J].

Robert, Caroline ;

Schachter, Jacob ;

Long, Georgina V. ;

Arance, Ana ;

Grob, Jean Jacques ;

Mortier, Laurent ;

Daud, Adil ;

Carlino, Matteo S. ;

McNeil, Catriona ;

Lotem, Michal ;

Larkin, James ;

Lorigan, Paul ;

Neyns, Bart ;

Blank, Christian U. ;

Hamid, Omid ;

Mateus, Christine ;

Shapira-Frommer, Ronnie ;

Kosh, Michele ;

Zhou, Honghong ;

Ibrahim, Nageatte ;

Ebbinghaus, Scot ;

Ribas, Antoni .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2521-2532

[79] Nivolumab in Previously Untreated Melanoma without BRAF Mutation [J].

Robert, Caroline ;

Long, Georgina V. ;

Brady, Benjamin ;

Dutriaux, Caroline ;

Maio, Michele ;

Mortier, Laurent ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

McNeil, Catriona ;

Kalinka-Warzocha, Ewa ;

Savage, Kerry J. ;

Hernberg, Micaela M. ;

Lebbe, Celeste ;

Charles, Julie ;

Mihalcioiu, Catalin ;

Chiarion-Sileni, Vanna ;

Mauch, Cornelia ;

Cognetti, Francesco ;

Arance, Ana ;

Schmidt, Henrik ;

Schadendorf, Dirk ;

Gogas, Helen ;

Lundgren-Eriksson, Lotta ;

Horak, Christine ;

Sharkey, Brian ;

Waxman, Ian M. ;

Atkinson, Victoria ;

Ascierto, Paolo A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :320-330

[80] Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution [J].

Ryder, Mabel ;

Callahan, Margaret ;

Postow, Michael A. ;

Wolchok, Jedd ;

Fagin, James A. .

← 1 2 3 4 5 6 7 8 9 10 →